HealthProves
Symptom-centric view

Myelosuppression

Substances reporting Myelosuppression disproportionately — ranked by ROR.

PainDrug ineffectiveOff label useFatigueDyspnoeaAcute kidney injury
showing 91 of 91
Substance ↓ROR [95% CI]ReportsCategoryLabel
27.6 [20.4–37.4]44algemeennew
39.9 [34.8–45.7]221algemeennew
17.0 [15.8–18.3]716algemeennew
9.7 [6.7–14.1]28algemeennew
29.9 [28.7–31.2]2,438algemeennew
10.6 [9.2–12.3]191algemeennew
9.2 [8.1–10.4]256algemeennew
9.2 [8.1–10.4]256algemeennew
28.2 [27.2–29.3]3,259algemeennew
10.3 [9.2–11.5]319algemeennew
25.7 [22.2–29.8]184algemeennew
25.7 [22.2–29.8]184algemeennew
16.4 [14.9–18.1]432algemeennew
55.5 [53.8–57.3]4,774algemeennew
55.5 [53.8–57.3]4,774algemeennew
14.3 [13.9–14.8]4,907algemeennew
12.2 [9.7–15.3]78algemeennew
8.1 [6.4–10.1]75algemeennew
21.8 [13.6–34.8]18algemeennew
18.7 [16.5–21.2]254algemeennew
35.1 [33.2–37.0]1,504algemeennew
15.1 [14.1–16.2]816algemeennew
15.1 [14.1–16.2]816algemeennew
11.9 [10.4–13.6]215algemeennew
19.3 [16.4–22.7]147algemeennew
15.8 [13.4–18.7]147algemeennew
29.6 [28.5–30.7]3,136algemeennew
25.6 [24.6–26.5]3,280algemeennew
15.6 [14.9–16.4]1,611algemeennew
7.0 [6.3–7.8]322algemeennew
13.7 [12.4–15.1]411algemeennew
21.5 [19.7–23.5]500algemeennew
13.7 [11.5–16.3]127algemeennew
13.7 [11.5–16.3]127algemeennew
12.2 [10.3–14.3]148algemeennew
11.9 [10.1–14.0]148algemeennew
13.5 [12.2–15.1]345algemeennew
2.1 [1.5–2.8]39algemeennew
8.1 [7.3–9.0]354algemeennew
29.8 [24.9–35.7]125algemeennew
23.9 [20.0–28.6]126algemeennew
23.8 [19.9–28.4]126algemeennew
13.8 [12.5–15.3]382algemeennew
19.3 [15.6–23.9]86algemeennew
17.2 [12.7–23.4]42algemeennew
36.8 [34.0–39.9]650algemeennew
8.5 [6.1–11.7]37algemeennew
16.8 [15.3–18.3]518algemeennew
13.2 [9.7–17.9]42longevitynew
6.1 [3.9–9.6]19algemeennew
51.9 [45.9–58.6]278algemeennew
21.1 [20.0–22.2]1,546algemeennew
21.0 [20.0–22.1]1,546algemeennew
14.1 [12.3–16.1]219algemeennew
13.6 [11.9–15.6]219algemeennew
34.7 [29.8–40.4]177algemeennew
25.9 [22.0–30.6]150algemeennew
11.3 [10.7–12.0]1,240algemeennew
15.0 [13.0–17.2]206algemeennew
18.0 [17.1–18.8]1,861algemeennew
58.6 [52.1–66.0]303algemeennew
77.2 [71.1–83.9]643algemeennew
14.2 [12.0–16.8]139algemeennew
10.8 [9.7–12.1]305algemeennew
16.6 [15.4–17.8]772algemeennew
10.8 [10.2–11.3]1,458algemeennew
23.3 [22.3–24.4]2,146algemeennew
23.3 [22.3–24.4]2,146algemeennew
10.9 [10.3–11.4]1,725algemeennew
29.7 [27.0–32.8]423algemeennew
52.6 [47.3–58.6]366algemeennew
9.5 [8.7–10.3]584algemeennew
8.2 [6.6–10.1]90algemeennew
25.3 [24.2–26.4]2,133algemeennew
10.1 [7.2–14.1]34algemeennew
18.2 [17.6–18.9]4,137algemeennew
18.2 [17.6–18.9]4,137algemeennew
18.2 [17.6–18.9]4,137algemeennew
23.7 [22.7–24.7]2,486algemeennew
12.7 [11.7–13.8]582algemeennew
21.4 [20.7–22.2]3,512algemeennew
9.3 [8.8–9.8]1,225algemeennew
16.0 [14.1–18.2]238algemeennew
8.1 [6.8–9.7]125algemeennew
11.5 [11.0–12.0]2,071algemeennew
15.1 [13.3–17.0]266algemeennew
57.1 [53.9–60.4]1,358algemeennew
36.5 [34.6–38.5]1,467algemeennew
12.0 [9.1–15.8]52algemeennew
13.7 [11.7–15.9]170algemeennew
17.8 [16.3–19.5]493algemeennew

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).